Cytarabine (ara-C)
Updated September 2026.
Also known as: ara-C, Cytosar
Fakes a DNA building block so dividing leukemia cells cannot copy themselves. Often given as a run of shots.
Cytarabine (ara-C) is a look-alike. It is almost identical to cytidine, one of the four building blocks of DNA, with one small change in its sugar. Depending on the phase of treatment it is given as shots under the skin, through the line, or into the spinal fluid.
Cells take it up and, treating it as the real thing, build it into the growing DNA copy. Once the fake block is in place the copying machinery cannot add the next one properly and the chain stalls. A cell stuck halfway through copying its DNA dies. Cells that are not dividing barely notice it, which is why it matters most to leukemia cells.
I made an everyday analogy and a more scientific visualization of cytarabine.
Everyday analogy
Cytarabine: a faulty link leaves the chain unfinished.
1 / 3 Copy the original chain
The machine copies a chain, adding ordinary links one by one.
2 / 3 A faulty link stalls the copy
A faulty teal link goes in, but the next link cannot attach.
3 / 3 Set the unfinished copy aside
The copy cannot be finished. It drops into the unfinished tray.
The teal link represents the altered building block formed from cytarabine inside a cell. It can become part of DNA and interfere with further copying.
The original chain is the pattern. Making a matching chain is like copying DNA, the cell’s instructions.
The unfinished chain shows a failed copying job. A cell may die when it cannot finish copying its DNA. The tray is only part of the analogy.
Press play below for a more accurate visualization.
Interactive visual
How cytarabine disguises itself as a DNA building block and jams the copier
Side effects
The full list, kept up to date:
- Cytarabine — Together by St. Jude · written for families by a children's cancer hospital
- Cytarabine injection — MedlinePlus · U.S. National Library of Medicine
Where I read this
- FDA prescribing information on DailyMed · section 12.1, mechanism of action
- Childhood ALL treatment (PDQ), National Cancer Institute · where each drug fits in treatment
